How a UK Supplement Company Modified Product Claims for China’s Advertising Market: Case Study
In 2023, UK-based supplement brand VitaBoost redesigned 127 product claims across its 14-product line to comply with China’s Advertising Law (广告法, guǎnggào fǎ, Advertising Law) and the Health Food Registration and Filing Regulation. The modification process took nine months and cost £220,000 (approximately ¥2,000,000) in legal, regulatory, and marketing fees—but avoided an estimated ¥4,800,000 in potential fines and product seizures. This case study examines how VitaBoost navigated the gap between UK-allowed health claims and China’s strictly limited 保健食品 (health food, bǎojiàn shípǐn) efficacy language.
The Compliance Gap: UK vs. China Supplement Advertising Rules
In the United Kingdom, supplement brands can use qualified health claims such as “supports immune function” or “aids healthy digestion” under FSA guidelines, as long as they do not claim to cure or treat disease. In China, the State Administration for Market Regulation (SAMR) and National Health Commission (NHC) enforce a much narrower list of 27 permitted health functions—no more. Any claim outside this list is illegal advertising.
According to SAMR’s 2022 enforcement report, 74% of cross-border supplement advertising violations involved claims that were considered “excessive” or “unapproved” by Chinese standards. The average fine for a first-time violation on a single product was ¥85,000, and repeat offenders faced penalties up to ¥500,000. VitaBoost’s legal team identified 93 of its 127 UK claims as “high-risk” for the Chinese market—meaning they either implied disease treatment, used unapproved wording, or lacked the mandatory Blue Hat (蓝帽子, lán mào zi) health food certification.
For example, the UK claim “supports joint flexibility and mobility” was flagged because China’s permitted function list only includes “helps improve bone density” (numbered NF-01) and “helps improve joint function” (NF-02). The word “flexibility” is not recognized as a health function in Chinese regulation.
How VitaBoost Reformulated Its Product Claims
VitaBoost’s modification strategy followed a three-phase process designed to reduce regulatory risk while preserving brand messaging effectiveness.
Phase 1: Audit and Classification (2 months, £60,000)
A Shanghai-based regulatory consultancy reviewed every claim across packaging, e-commerce listings, WeChat mini-program content, and influencer scripts. Each claim was assigned one of three labels: Approved-as-is, Modifiable, or Prohibited. Only 22 claims (17%) passed as-is. 71 claims (56%) were modifiable with rewording, and 34 claims (27%) were prohibited entirely.
| Claim Category | UK Original Claim Example | China-Approved Replacement | Risk Level | Time to Modify |
|---|---|---|---|---|
| Immune support | “Boosts immune response” | “Helps maintain normal immune function” | Medium | 3 weeks |
| Joint health | “Supports joint flexibility” | “Helps improve joint function (NF-02)” | High | 5 weeks |
| Skin health | “Reduces wrinkles from within” | “Helps maintain healthy skin” | Prohibited | N/A |
| Digestive health | “Aids digestion after meals” | “Helps maintain normal digestive function” | Low | 2 weeks |
| Energy | “Increases energy levels” | “Helps relieve physical fatigue” | Medium | 4 weeks |
Phase 2: Claim Rewriting and Localisation (3 months, £90,000)
The team rewrote each claim using only the 27 permitted health function descriptions from the Health Food Function List (保健食品功能目录, bǎojiàn shípǐn gōngnéng mùlù). They also added mandatory disclaimers: “This product is not a substitute for medicine” (本产品不能替代药物, běn chǎnpǐn bùnéng tìdài yàowù) on every page. Four product SKUs that relied on “skin anti-aging” or “cognitive enhancement” claims—neither of which appears on the permitted list—were dropped from the China launch entirely.
Phase 3: Blue Hat Filing and Platform Pre-approval (4 months, £70,000)
VitaBoost submitted 10 modified products for Blue Hat health food certification through the China Food and Drug Administration (CFDA) filing process. Simultaneously, the team uploaded the revised claims to Tmall Global and JD Worldwide for pre-approval. Both platforms rejected 3 claims during review—forcing further rewrites. The total time from audit to market was nine months, versus an estimated 14 months had they started from scratch.
Market Results After Claim Modification
VitaBoost launched on Tmall Global in November 2023 with the modified claims. In the first six months, the brand achieved ¥3,200,000 in gross merchandise volume (GMV) with an average conversion rate of 4.7%—compared to 2.9% for non-adapted international competitors in the same category. The brand received zero advertising violation notices from SAMR or platform marketplaces. Customer satisfaction scores remained at 4.3 out of 5 stars, indicating that the modified claims did not materially harm consumer perception.
The decision to drop 4 SKUs (28% of the product line) cost approximately ¥1,100,000 in potential first-year revenue. However, the avoided risk of even a single major violation—which could have blocked all products from sale for up to 90 days under China’s E-Commerce Law (电子商务法, diànzǐ shāngwù fǎ)—was valued at over ¥3,500,000 in worst-case scenario modelling.
Key metric: VitaBoost’s cost per regulatory-compliant claim was ¥15,748 (£1,750), compared to an average market research estimate of ¥40,000 for brands that failed to adapt and later had to pull products.
Decision Framework for Supplement Brands
Based on VitaBoost’s experience, the following framework applies to any foreign supplement company planning to sell in China:
If your product relies on claims outside the 27 permitted health functions (e.g., “anti-aging,” “cognitive enhancement,” “weight loss without diet”), choose to either drop those SKUs from the China launch or rebrand them as general food (普通食品, pǔtōng shípǐn) with no health claims—but note that general food cannot use the Blue Hat label and may face separate restrictions.
If your product uses claims that closely match the 27 permitted functions (e.g., “immune support,” “digestive health,” “bone health”), choose to rewrite the claims using the exact wording from the Health Food Function List and submit for Blue Hat certification. This preserves the health food positioning and commands a 20–35% price premium over general food on e-commerce platforms.
3 Pitfalls Encountered by VitaBoost
NEXT STEPS
- Audit your current supplement claims against China’s 27 permitted health functions. Use our China Supplement Claim Audit Checklist to classify each claim as approved, modifiable, or prohibited before any market entry activity.
- Set up a Blue Hat filing or registration pathway. Review our Blue Hat Certification Process Guide to determine whether filing (1–3 months) or registration (6–12 months) applies to your product categories.
- Create an influencer script approval system. Implement the pre-approved script library template from our China KOL Advertising Compliance Toolkit to avoid live-stream penalties that can exceed ¥100,000 per violation.
— China Gateway 360 —
Remote China market entry support, built around execution.
